In the current study, we adopted siRNA technology to knock down the expression of KIAA0100 in MDA-MB-231 cells, a highly aggressive triple negative breast cancer cell line [20,21], as a model to study its potential molecular and cellular roles associated with aggressive behavior of breast cancer cells. Here, BLTP2 is linked to breast carcinoma.